The US Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups.

Mehta said HUL's focus would continue to ensure uninterrupted supplies of COVID relevant portfolio and meeting the demand arising out of evolving consumer needs ...

In a report released today, Peter Welford from Jefferies downgraded GlaxoSmithKline (GSK – Research Report) to a Hold, with a price ...

GSK Plc said its blood cancer drug significantly reduced the risk of death when combined with another cancer treatment, ...

GSK spun off Haleon to form a new consumer healthcare entity, driven by activist investor pressure and its underperforming share price. Haleon’s financials show steady growth with 2023 revenues ...

Haleon backed its full-year guidance despite lower third-quarter revenue and earnings, although organic revenue growth of 6.1% topped its own forecasts.

GSK CEO Emma Walmsley's bet on blockbuster RSV vaccine, Arexvy, has hit a snag in recent months after the U.S. public health agency ... Marketscategory Argentine consumers feel squeezed even ...

Bernstein analyst Justin Smith maintained a Buy rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of ...

Phenylephrine:CVS pulls cold medicines with the ingredient Companies such as Procter & Gamble and GSK were among several accused ... or remove such drugs from the market. The Consumer Healthcare ...

Moderna to defend against GSK's claims, spokesperson says GSK seeks ... Thomson Reuters Practical Law and practiced as an attorney. Healthcare & Pharmaceuticalscategory Vital signs improve for ...

Mumbai: On 12 November 2024, Fireside Ventures, an early-stage venture fund focused on consumer brands, appointed Adarsh ...

While generics may dominate due to cost advantages and meeting needs of a developing economy, there is a growing thrust ...